NCT05742204View on ClinicalTrials.gov

Plasma Proteomic Biomarkers for Early Diagnosis of Lung Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

3,700

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

May 1, 2025

Study Completion Date

October 31, 2032

Conditions
Lung Cancer
Interventions
OTHER

Plasma protein biomarker analysis

Plasma samples from lung cancer patients were collected at the time of their diagnosis, prior to the initiation of treatment.We will use TMT-based proteomics approaches to analyze more than 2000 proteins in plasma samples from lung cancer patients .

OTHER

Plasma protein biomarker analysis

Plasma samples of control subjects were collected.

Trial Locations (1)

310009

2nd Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER